- Home
- HOOD vs TAK Comparison
HOOD vs TAK Comparison
Compare HOOD & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOD
- TAK
- Stock Information
- Founded
- HOOD 2013
- TAK 1781
- Country
- HOOD United States
- TAK Japan
- Employees
- HOOD N/A
- TAK N/A
- Industry
- HOOD Computer Software: Prepackaged Software
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- HOOD Technology
- TAK Health Care
- Exchange
- HOOD Nasdaq
- TAK Nasdaq
- Market Cap
- HOOD 54.5B
- TAK 45.8B
- IPO Year
- HOOD 2021
- TAK N/A
- Fundamental
- Price
- HOOD $78.50
- TAK $14.76
- Analyst Decision
- HOOD Buy
- TAK
- Analyst Count
- HOOD 23
- TAK 0
- Target Price
- HOOD $63.71
- TAK N/A
- AVG Volume (30 Days)
- HOOD 35.2M
- TAK 1.9M
- Earning Date
- HOOD 08-06-2025
- TAK 07-30-2025
- Dividend Yield
- HOOD N/A
- TAK 4.01%
- EPS Growth
- HOOD 1117.91
- TAK N/A
- EPS
- HOOD 1.75
- TAK 0.45
- Revenue
- HOOD $3,260,000,000.00
- TAK $30,595,075,281.00
- Revenue This Year
- HOOD $28.02
- TAK $1.01
- Revenue Next Year
- HOOD $15.11
- TAK $1.04
- P/E Ratio
- HOOD $44.96
- TAK $63.71
- Revenue Growth
- HOOD 59.65
- TAK 7.45
- 52 Week Low
- HOOD $13.98
- TAK $12.58
- 52 Week High
- HOOD $79.32
- TAK $15.43
- Technical
- Relative Strength Index (RSI)
- HOOD 71.28
- TAK 46.62
- Support Level
- HOOD $72.86
- TAK $14.86
- Resistance Level
- HOOD $75.59
- TAK $15.42
- Average True Range (ATR)
- HOOD 3.69
- TAK 0.14
- MACD
- HOOD -0.05
- TAK -0.03
- Stochastic Oscillator
- HOOD 93.71
- TAK 9.47
About HOOD Robinhood Markets Inc.
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.